Cantor Fitzgerald Reiterates Overweight Rating on Pacific Biosciences of California (PACB)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
| PACIFIC BIO CA (NASDAQ: PACB) | Delayed: 2.55 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.55 | 52 Week High | $14.00 | |||
| Open | $2.55 | 52 Week Low | $6.61 | |||
| Day High | $2.55 | P/E | N/A | |||
| Day Low | $2.55 | EPS | $-1.26 | |||
| Volume | 77,362 | |||||
